Pliant Therapeutics, Inc. (NASDAQ: PLRX)
$12.0050
-0.6050 ( -2.08% ) 150.7K
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
Market Data
Open
$12.0050
Previous close
$12.6100
Volume
150.7K
Market cap
$730.85M
Day range
$11.8830 - $13.0140
52 week range
$10.2200 - $18.9199
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 06, 2024 |
| 10-q | Quarterly Reports | 85 | May 06, 2024 |
| def | Proxies and info statements | 19 | Apr 22, 2024 |